BioAdvance

BioAdvance

BioAdvance

BioAdvance actively invests venture capital in therapies, medical devices, research tools, diagnostics and health IT in the MidAtlantic region.
Follow us
Alexa global traffic share
Latest investments Show all
$3,800,000
Venture capital (Series A)
WellSheet
$45,000,000
Venture capital (Series C)
Palvella Therapeutics
Team Size
1–10
Employees
Geographical Focus
Past year's investments
  • 3 rounds in the past year
  • $60.8M deployed in total
  • $20.3M avg per round
Latest rounds
  • WellSheet: Venture capital (Series A) ($3.8M)
  • Palvella Therapeutics: Venture capital (Series C) ($45M)
  • Halo Labs: Venture capital (Series B) ($12M)